Peter P, Kiene K, Gonvers J J, Pelloni S, Weber K, Sonnenberg A, Schmitz H, Richter O, Hofstetter J R, Blum A L, Strohmeyer G
Dtsch Med Wochenschr. 1978 Jul 21;103(29):1163-6. doi: 10.1055/s-0028-1129221.
In a double-blind trial of patients with duodenal ulcer at three centres the healing rate after a four-week course of treatment (1 g cimetidine daily) was 79% (30 out of 38 patients), compared with 58% (23 out of 40 patients) on placebos. Cimetidine did not effect subjective symptoms or the need for antacids to relieve pain, except for a minor beneficial effect on diurnal ulcer symptoms during the second week of treatment. Results of long-term administration suggest that cimetidine at 400 mg daily prevent s relapses, but the possibility of an increased relapse rate after cimetidine withdrawal can not as yet be excluded.
在三个中心对十二指肠溃疡患者进行的一项双盲试验中,接受为期四周的治疗疗程(每日1克西咪替丁)后,愈合率为79%(38例患者中有30例),而服用安慰剂的患者愈合率为58%(40例患者中有23例)。西咪替丁对主观症状或使用抗酸剂缓解疼痛的需求没有影响,不过在治疗的第二周对日间溃疡症状有轻微的有益作用。长期给药的结果表明,每日400毫克的西咪替丁可预防复发,但目前尚不能排除停用西咪替丁后复发率增加的可能性。